[ad_1]
SEATTLE, March 30, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global duck medicine and vaccines market is estimated to be valued at US$ 1,777.0 million in 2021 and is expected to exhibit a CAGR of 7.7% during the forecast period (2021-2028).
Key Trends and Analysis of the Global Duck Medicine and Vaccines Market:
Key trends in the market include increased research and development activities by the key players and scientists, which are expected to drive the market growth over the forecast period. For instance, in April 2018, researchers at the Pirbright Institute, a research institute in Surrey, England, developed a single vaccine for avian flu and duck enteritis. The researchers used a method of CRISPR/Cas9 gene editing that allows higher rates of gene editing, making the process more efficient. The resulting vaccine can protect ducks against both duck enteritis virus ( DEV) and avian influenza.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4956
Key Market Takeaways:
The global duck medicine and vaccines market is expected to exhibit a CAGR of 7.7% during the forecast period due to the increasing research and development program by the government, which is expected to drive the market growth over the forecast period. For instance, in 2018 , the NER Duck program was initiated by the Indian government that focuses on breeding of duck by converging conventional and molecular techniques, disease mapping and development of diagnostics for economically important diseases, developing molecular platform for epidemiology, development of vaccine against duck plague virus, and others.
Among the type, the vaccines segment is estimated to hold a dominant position over the forecast period, owing to the routine immunizations carried out for the prevention of …
Full story available on Benzinga.com
[ad_2]
Source link
